Skip to main content

Medication Treatment of Bipolar Disorder in Developmentally Disabled Children and Adolescents

  • Chapter
Treating Childhood Psychopathology and Developmental Disabilities

If systematic data on the treatment of bipolar disorder in children and adolescents is meager, information on treatment of bipolar disorder in developmentally disabled children is virtually nonexistent. Not only are many of the challenges to diagnosing young children relevant to persons with autism and intellectual disability of any age, but also, accumulating a sample size large enough to randomize to treatment alternatives would require financial resources that are not likely to be forthcoming any time soon. This chapter, then, begins with a review of the treatment of bipolar disorder (BD) in normally developing youth, summarizes current treatment of BD in adults with developmental disabilities (DD), and then moves to the review of available literature on the treatment of developmentally disabled children and adolescents with BD. We conclude with our thoughts about treatment in this vulnerable population.

Our understanding of BD as a recurrent disorder in which mood and activity level are either significantly increased (hypomania and mania) or decreased (depression) with return to premorbid levels of functioning in between emerged largely from the vast clinical experience of psychiatrists such as Kraepelin in the early 20th century recognizing syndromal similarities of hundreds of his patients. Our initial understanding of BD in youth, however, emerged from attempts to find pediatric equivalents of what adult psychiatrists appeared to be describing (see Glovinsky, 2002; Carlson, 2005). This form of manic depressive illness did indeed exist in youths, occurred mostly in adolescents, was depressive, and familial. In the early 1950s, a volume of a journal called The Nervous Child raised the issue of an “alternative form” of manic depression, children whose behavior fluctuated and might be construed as cycling. Anthony and Scott (1960) explored the question of strictly defined, classical “manic depressive psychosis” in preadolescents in a literature review, and they found it to be uncommon, generally beginning to emerge at around age 11.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adams, G. L., Kivowitz, J., & Ziskind, E. (1970). Manic depressive psychosis, mental retardation, and chromosomal rearrangement. Archives of General Psychiatry, 23, 305–309.

    PubMed  Google Scholar 

  • Allison,D. B., Mentore, J. L., Heo, M., Chandler,L. P., Cappelleri, J. C., Infante, M. C. & Weiden, P. J. (1999). Antipsychotic-induced weight gain: A comprehensive research synthesis. American Journal of Psychiatry, 156, 1686–1696.

    PubMed  Google Scholar 

  • Altshuler, L. L., Keck, P. E. Jr., McElroy, S. L., Suppes, T., Brown, E. S., Denicoff, K., Frye, M., Gitlin, M., Hwang, S., Goodman, R., Leverich, G., Nolen, W., Kupka, R., & Post, R. (1999). Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disorder, 1, 61–65.

    Article  Google Scholar 

  • Aman, M. G., Collier-Crespin, A., & Lindsay, R.L. (2000). Pharmacotherapy of disorders in mental retardation. European Child & Adolescent Psychiatry, 9, I98–107.

    Article  Google Scholar 

  • Aman, M. G., De Smedt, G., Derivan, A., Lyons, B., & Findling, R.L. (2002). Risperidone disruptive behavior study group. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. American Journal of Psychiatry, 159, 1337–1346.

    Article  PubMed  Google Scholar 

  • Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiencies, 89, 485–491.

    Google Scholar 

  • Andreasen, N. (2007). DSM and the death of phenomenology in America: an example of unintended consequences. Schizophrenia Bulletin, 33, 108.

    Article  PubMed  Google Scholar 

  • Anthony, E. J., & Scott, P. (1960). Manic-depressive psychosis in childhood. Journal of Child Psychology and Psychiatry 1, 53–72.

    Article  Google Scholar 

  • Antonacci, D. J., & de Groot, C. M. (2000). Clozapine treatment in a population of adults with mental retardation. Journal of Clinical Psychiatry, 61, 22–25.

    PubMed  Google Scholar 

  • Baldessarini, R. J., Tondo, L., & Viguera, A. C. (1999). Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disorder, 1, 17–24.

    Article  Google Scholar 

  • Buitelaar, J. K., van der Gaag, R. J., Cohen-Kettenis, P., & Melman, C. T. (2001). A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. Journal of Clinical Psychiatry, 62, 239–248.

    PubMed  Google Scholar 

  • Buzan, R. D., Dubovsky, S. L., Firestone, D., & Dal Pozzo, E. (1998). Use of clozapine in 10 mentally retarded adults. Journal of Neuropsychiatry and Clinical Neuroscience, 10, 93–95.

    Google Scholar 

  • Cain, N. N., Davidson, P. W. Burhan, A. M., Andolsek, M. E., Baxter, J. T., Sullivan, L., Florescue, H. List, A. & Deutsch, L. (2003). Identifying bipolar disorders in individuals with intellectual disability. Journal of Intellectual Disability Research, 47, 31–38.

    Article  PubMed  Google Scholar 

  • Calabrese, J. R., Keck, P. E., Jr., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., & Mullen, J. (2005). A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. American Journal of Psychiatry, 162, 1351–1360.

    Article  PubMed  Google Scholar 

  • Calabrese, J. R., Shelton, M. D., Rapport, D. J., Youngstrom, E. A., Jackson, K., Bilali, S., Ganocy, S. J., & Findling, R. L. (2005). A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. American Journal of Psychiatry, 162, 2152–2161.

    Article  PubMed  Google Scholar 

  • Campbell, M., Fish, B., Korein, J., Shapiro, T., Collins, P., & Koh, C. (1972). Lithium and chlorpromazine: a controlled crossover study of hyperactive severely disturbed young children. Journal of Autism and Child Schizophrenia, 2, 234–263.

    Article  Google Scholar 

  • Campbell, M., Small, A. M., Green, W. H., Jennings, S. J., Perry, R., Bennett, W. G., & Anderson, L. (1984). Behavioral efficacy of haloperidol and lithium carbonate. A comparison inhospitalized aggressive children with conduct disorder. Archives of General Psychiatry, 41, 650–656.

    PubMed  Google Scholar 

  • Carandang, C. G., Maxwell, D. J., Robbins, D. R., & Oesterheld, J. R. (2003). Lamotrigine in adolescent mood disorders. Journal of the American Academy of Child Adolescent Psychiatry, 42, 750–751.

    Article  Google Scholar 

  • Carlson, G. A. (1979). Affective psychoses in mental retardates. Psychiatric Clinics of North America, 2, 499–510.

    Google Scholar 

  • Carlson, G. A. (2005). Early onset bipolar disorder: Clinical and research considerations. Journal of Clinical Child and Adolescent Psychology, 34, 333–343.

    Article  PubMed  Google Scholar 

  • Carlson, G. A., & Meyer, S. E. (2006). Diagnosis of bipolar disorder across the lifespan: complexities and developmental issues. Developmental Psychopathology, 18, 939–969.

    Article  Google Scholar 

  • Carlson, G. A., & Meyer, S. E. (2006). Diagnosis of bipolar disorder across the lifespan: complexities and developmental issues. Developmental Psychopathology, 18, 939–969.

    Article  Google Scholar 

  • Carlson, G. A., & Mick, E. (2003). Drug-induced disinhibition in psychiatrically hospitalized children. Journal of Child and Adolescent Psychopharmacology, 13, 153–164.

    Article  PubMed  Google Scholar 

  • Carlson, G. A., & Strober, M. (1978). Manic-depressive illness in early adolescence. A study of clinical and diagnostic characteristics in six cases. Journal of the American Academy of Child Psychiatry, 17, 138–153.

    Article  PubMed  Google Scholar 

  • Casey, D. E., Haupt, D. W., Newcomer, J. W., Henderson, D. C., Sernyak, M. J., & Davidson, M. (2004). Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. Journal of Clinical Psychiatry, 65, 4–18.

    PubMed  Google Scholar 

  • Chang, K., Saxena, K., & Howe, M. (2006).An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 298–304.

    Article  PubMed  Google Scholar 

  • Correll, C. U., Lencz, T., Smith, C. W., Auther, A. M., Nakayama, E, Y., Hovey, L., Olsen, R., Shah, M., Foley, C., Cornblatt, B. A. (2005) Prospective study of adolescents with subsyndromal psychosis: characteristics and outcome. J Child Adolesc Psychopharmacol, 15(3):418–433.

    Article  PubMed  Google Scholar 

  • Corson, A. H., Barkenbus, J. E., Posey, D. J., Stigler, K. A., & McDougle, C. J. A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders. Journal of Clinical Psychiatry, 65, 1531–1536.

    Google Scholar 

  • Damore, J., Stine, J., & Brody, L. (1998). Medication-induced hypomania in Asperger's disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 248–249.

    Article  PubMed  Google Scholar 

  • DeJong, S. & Frazier, J. A. (2002). Bipolar disorder in children with pervasive developmental disorder. In B. Geller & M. P. DelBello (Eds.), Bipolar Disorder in Childhood and Early Adolescence (51–75). New York: Guildford Press.

    Google Scholar 

  • Dostal, T., & Zvolsky, P. (1970). Antiagressive effects of lithium salts in severe mentally retarded adolescents. International Pharmacopsychiatry, 5, 203–207.

    Google Scholar 

  • Elliott, R. L. (1986). Lithium treatment and cognitive changes in two mentally retarded patients. Journal of Nerve and Mental Disorders, 174, 689–692.

    Article  Google Scholar 

  • Faraone, S. V., Biederman, J., Wozniak, J., Mundy, E., Mennin, D., & O'Donnell, D. (1997). Is comorbidity a marker for Juvenile-onset mania? Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1046–1055.

    PubMed  Google Scholar 

  • Frazier, J. A., Doyle, R., Chiu, S., & Coyle, J. T. (2002). Treating a child with Asperger's disorder and comorbid bipolar disorder. American Journal of Psychiatry, 159, 13–21.

    Article  PubMed  Google Scholar 

  • Frazier J. A. & Jackson J. A. (2008). Atypical Antipsychotics in the Treatment of Early Onset Bipolar Disorder, In: B. Geller & M. Delbello (Eds). Treating Child and Adolescent Bipolar Disorder, pp. 69–108.

    Google Scholar 

  • Friedman, D. L., Kastner, T., Plummer, A. T., Ruiz, M. Q., & Henning, D. (1992). Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine. American Journal of Mental Retardation, 96, 541–546.

    PubMed  Google Scholar 

  • Fukuda, K., Etoh, T., & Okuma, T. (1986). Affective disorders in mentally retarded adolescents—Report of two cases with lithium treatment. Japanese Journal of Psychiatry and Neurology, 40, 551–557.

    PubMed  Google Scholar 

  • Geller, B., Cooper, T. B., Zimerman, B., Frazier, J., Williams, M., Heath, J., Warner, K. (1998). Lithium for prepubertal depressed children with family history predictors of future bipolarity: a double-blind, placebo-controlled study. J Affect Disord, 51(2), 165–175.

    Article  PubMed  Google Scholar 

  • Ghaemi, S. N., Hsu, D. J., Soldani, F., & Goodwin, F. K. (2003). Antidepressants in bipolar disorder: The case for caution. Bipolar Disorders, 5, 421–433.

    Article  PubMed  Google Scholar 

  • Ghaziuddin, N., Kutcher, S.P., & Knapp, P. (2004). American Academy of Child and Adolescent Psychiatry Work Group on Quality Issues. Summary of the practice parameter for the use of electroconvulsive therapy with adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 119–122.

    Article  PubMed  Google Scholar 

  • Glovinski, I. (2002). A brief history of childhood-onset bipolar disorder through 1980. Child and Adolescent Psychiatric Clinics of North America, 11, 443–460.

    Article  Google Scholar 

  • Glue, P. (1989). Rapid cycling affective disorders in the mentally retarded. Biological Psycthiatry, 26(3), 250–256.

    Article  Google Scholar 

  • Goetzl, U., Grunberg, F., & Berkowitz, B. (1977). Lithium carbonate in the management of hyperactive aggressive behavior of the mentally retarded. Comprehensive Psychiatry, 18, 599–606.

    Article  PubMed  Google Scholar 

  • Goldberg, J. F. (2003). When do antidepressants worsen the course of bipolar disorder? Journal of Psychiatric Practice, 9, 181–194.

    Article  PubMed  Google Scholar 

  • Goodwin, G. M., Bowden, C. L., Calabrese, J. R., Gunze, H., Kasper, S., White, R., Greene, P., & Ledbetter, R. (2004). A pooled analysis of 2 placebo-controlled 18 month trials of lamotrigine and lithium maintenance in bipolar I disorder. Journal of Clinical Psychiatry, 65, 431–441.

    Article  Google Scholar 

  • Gram, L. F., & Rafaelsen, O. J. (1972). Lithium treatment of psychotic children and adolescents. A controlled clinical trial. Acta Psychiatrica Scandinavica, 48, 253.

    Article  PubMed  Google Scholar 

  • Gutkovich, Z. A., Carlson, G. A., Carlson, H. E., Coffey, B., & Wieland, N. (2007). Asperg-er's disorder and co-morbid bipolar disorder: Diagnostic and treatment challenges. Journal of Child and Adolescent Psychopharmacology, 17, 247–256

    Article  PubMed  Google Scholar 

  • Guze, B.H., Weinman, B., & Diamond, R.P. (1987). Use of ECT to treat bipolar depression in a mental retardate with cerebral palsy. Convulsive Therapy, 3, 60–64.

    PubMed  Google Scholar 

  • Hammad, T. A. (2004). Relationship between psychotropic drugs and pediatric suicidal-ity. Report to U.S. Food & Drug Administration, August 16.

    Google Scholar 

  • Hammad, T. A., Laughren, T. P., & Racoosin, J. A. (2006). Suicide rates in short-term randomized controlled trials of newer antidepressants. Journal of Clinical Psychop-harmacology, 26, 203–207

    Article  Google Scholar 

  • Hardan, A. Y., Jou, R. J., & Handen, B. L. (2005). Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders. Journal of Autism and Developmental Disorders, 35, 387–391.

    Article  PubMed  Google Scholar 

  • Hasan, M. K., & Mooney, R. P. (1979). Three cases of manic-depressive illness in mentally retarded adults. American Journal of Psychiatry, 136, 1069–1071.

    PubMed  Google Scholar 

  • Hellings, J. A. (2006). Much improved outcome with gabapentin-divalproex combination in adults with bipolar disorders and developmental disabilities. Journal of Clinical Psychopharmacology, 26, 344–346.

    Article  PubMed  Google Scholar 

  • Hellings, J. A., Weckbaugh, M., Nickel, E. J., Cain, S. E., Zarcone, J. R., Reese, R. M., Hall, S., Ermer, D. J., Tsai, L. Y., Schroeder, S. R., & Cook, E. H. (2005). A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 15, 682–692.

    Article  PubMed  Google Scholar 

  • Hollander, E., Dolgoff-Kaspar, R., Cartwright, C., Rawitt, R., & Novotny, S. (2001). An open trial of divalproex sodium in autism spectrum disorders. Journal of Clinical Psychiatry, 62, 530–534.

    PubMed  Google Scholar 

  • Isojarvi, J., Laatikainen, T. J., Pakarinen, A. J., Juntunen, K., & Myllyla, V. V. (1993). Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. New England Journal of Medicine, 329, 1383–1388.

    Article  PubMed  Google Scholar 

  • Kafantaris,V., Coletti, D. J., Dicker, R., Padula, G., & Kane, J. M. (2001). Adjunctive antipsychotic treatment of adolescents with bipolar psychosis. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1448–1456.

    Article  PubMed  Google Scholar 

  • Kastner, T., Finesmith, R., & Walsh, K. (1993). Long-term administration of valproic acid in the treatment of affective symptoms in people with mental retardation. Journal of Clinical Psychopharmacology, 13, 448–451.

    Article  PubMed  Google Scholar 

  • Kastner, T., & Friedman D. L. (1992). Verapamil and valproic acid treatment of prolonged mania. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 271–275.

    Article  PubMed  Google Scholar 

  • Kastner, T., Friedman, D. L., Plummer, A. T., Ruiz, M. Q., & Henning, D. (1990). Valproic acid f or the treatment of children with mental retardation and mood symptomatology. Pediatrics, 86, 467–472.

    PubMed  Google Scholar 

  • Kelly, J. T., Koch, M., & Buegel, D. (1976). Lithium carbonate in juvenile manic- depressive illness. Diseases of the Nervous System, 37, 90–92.

    PubMed  Google Scholar 

  • Kerbeshian, J., Burd, L., & Fisher, W. (1987). Lithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomatology. Journal of Clinical Psychopharmacology, 7, 401–405.

    PubMed  Google Scholar 

  • Ketter T. A., Wang P. W., Nowakowska C., & Marsh W. K. (2004). New medication treatment options for bipolar disorders. Acta Psychiatr Scand Suppl, 422, 18–33.

    Article  PubMed  Google Scholar 

  • King, R., Fay, G., & Croghan, P. (2000). Rapid cycling bipolar disorder in individuals with developmental disabilities. Mental Retardation, 38, 253–261.

    Article  PubMed  Google Scholar 

  • Klein, D. J., Cottingham, E. M., Sorter, M., Barton, B. A. & Morrison, J. A. (2006). A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents. American Journal of Psychiatry, 163, 2072–2079.

    Article  PubMed  Google Scholar 

  • Komoto, J., Usui, S., & Hirata, J. (1984). Infantile autism and affective disorder. Journal of Autism and Developmental Disorders, 14, 81–84.

    Article  PubMed  Google Scholar 

  • Kowatch, R. A., Fristad, M., Birmaher, B., Wagner, K. D., & Findling, R. (2005). Treatment guidelines for children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 213–235.

    Article  PubMed  Google Scholar 

  • Kusumakar, V., & Yatham, L. N. (1997). An open study of lamotrigine in refractory bipolar depression. Psychiatry Research, 72, 145–148.

    Article  PubMed  Google Scholar 

  • Leibenluft, E., Charney, D. S., Towbin, K. E., Bhangoo, R. K., & Pine, D. S. (2003). Defining clinical phenotypes of juvenile mania. American Journal of Psychiatry, 160, 430–437.

    Article  PubMed  Google Scholar 

  • Lowry, M. A. (1993). Behavioral psychology update: A clear link between problem behaviors and mood disorders, The Habilitative Mental Healthcare Newsletter, 12, 105–110.

    Google Scholar 

  • Malone, R. P., Delaney, M. A., Luebbert, J. F., Cater, J., & Campbell, M. (2000). A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Archives of General Psychiatry, 57, 649–654.

    Article  PubMed  Google Scholar 

  • Maruta, K. (2003). Lithium intoxication in a patient with severe motor and intellectual disabilities. No To Hattatsu, 35, 422–425.

    PubMed  Google Scholar 

  • McClellan, J. (2005). Commentary: treatment guidelines for child and adolescent bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 236–239.

    Article  PubMed  Google Scholar 

  • McClellan, J., Kowatch, R., & Findling, R. L. (2007). Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 107–125.

    Article  PubMed  Google Scholar 

  • McCracken, J.T., & Diamond, R.P. (1988). Bipolar disorder in mentally retarded adolescents. Journal of American Academy of Child and Adolescent Psychiatry, 27, 494–499.

    Article  Google Scholar 

  • McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., McDougle, C. J., Posey, D., Swiezy, N., Kohn, A., Scahill, L., Martin, A., Koenig, K., Volkmar, F., Carroll, D., Lancor, A., Tierney, E., Ghuman, J., Gonzalez, N. M., Grados, M., Vitiello, B., Ritz, L., Davies, M., Robinson, J., McMahon, D. (2002). Research units on pediatric psychopharmacology autism network. Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347, 314–321.

    Article  PubMed  Google Scholar 

  • Messenheimer, J. (2002). Efficacy and safety of lamotrigine in pediatric patients. Journal of Child Neurology, Suppl 2, 2S34–2S42.

    Article  Google Scholar 

  • Naylor, G. J., Donald, J. M., Le Poidevin, D., & Reid, A. H. (1974). A double-blind trial of long-term lithium therapy in mental defectives. British Journal of Psychiatry, 124, 52–57.

    Article  PubMed  Google Scholar 

  • Pande, A. C., Crockatt, J. G., Janney, C. A., Werth, J. L., & Tsaroucha, G. (2000). Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disorders 2 (3 Pt 2), 249–255.

    Article  PubMed  Google Scholar 

  • Pary, R. (1991). Side effects during lithium treatment for psychiatric disorders in adults with mental retardation. American Journal on Mental Retardation, 96, 269–73.

    PubMed  Google Scholar 

  • Pavuluri, M. N., Henry, D. B., Devenini, B., Carbray, J. A., Naylor, M. W., & Janicak, P. G. (2004). A pharmacotherapy algorithm for stabilization and maintenance in bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 859–867.

    Article  PubMed  Google Scholar 

  • Poznanski, E. O., Grossman, J. A., Buchsbaum, Y., Banegas, M., Freeman, L., & Gibbons, R. (1984). Preliminary studies of the reliability and validity of the children's depression rating scale. Journal of the American Academy of Child Psychiatry, 23, 191–197.

    PubMed  Google Scholar 

  • Reid, A. H., Naylor, G. J., & Kay, D. S. (1981). A double-blind, placebo controlled, crossover trial of carbAmericanazepine in overactive, severely mentally handicapped patients. Psychological Medicine, 11(1), 109–113.

    Article  PubMed  Google Scholar 

  • Reinblatt, S. P., Rifkin, A., & Freeman, J. (2004). The efficacy of ECT in adults with mental retardation experiencing psychiatric disorders. Journal of ECT, 20, 208–212.

    Article  PubMed  Google Scholar 

  • Ruedrich, S. (1993). Bipolar mood disorders in persons with mental retardation: Assessment and diagnosis. In R. J. Fletcher & A. Dosen, (Eds.), Mental health aspects of mental retardation: Progress in assessment and treatment (pp. 111–129). New York: Lexington Books.

    Google Scholar 

  • Ryan, N. D., Meyer, V, Dachille, S, Mazzie, D, & Puig-Antich, J. (1988). Lithium antide-pressant augmentation in TCA-refractory depression in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 371–376.

    Article  PubMed  Google Scholar 

  • Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., Ketter, T. A., Patel, J., Hauser, P., Rapport, D., Martinez, J. M., Allen, M. H., Miklowitz, D. J., Otto, M. W., Dennehy, E. B., & Thase, M. E. (2007). Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine, 356, 1711–1722.

    Article  PubMed  Google Scholar 

  • Safer, D. J. & Zito, J. M. (2006). Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: Children versus adolescents. Journal of Child and Adolescent Psychopharmacology, 16, 159–169.

    Article  PubMed  Google Scholar 

  • Sovner, R. (1986). Limiting factors in the use of DSM—III criteria with mentally ill/mentally retarded persons. Psychopharmacology Bulletin, 22, 1055–1059. Handbook (179–200). OH: The Ohio State University.

    PubMed  Google Scholar 

  • Sovner, R. (1989). The use of valproate in the treatment of mentally retarded persons with typical and atypical bipolar disorders. Journal of Clinical Psychiatry, 50, 40–43.

    PubMed  Google Scholar 

  • Sovner, R. (1991). Divalproex-responsive rapid cycling bipolar disorder in a patient with Down's syndrome: implications for the Down's syndrome-mania hypothesis. Journal of Mental Deficiency Research, 35, 171–173.

    PubMed  Google Scholar 

  • Sovner, R., & Hurley, A. (1981). The management of chronic behavior disorders in mentally retarded adults with lithium carbonate. Journal of Nerve and Mental Disorders, 169, 191–195.

    Google Scholar 

  • Sovner, R., Pary, R. J., Dosen, A., Gedye, A., Barrera, F. J., Cantwell, D. P. & Huessy, H. R. (1998). Antidepressant drugs. In S. Reiss & M. G. Aman (Eds), Psychotropic Medications and Developmental Disabilities: The International Consensus Columbus, OH: The Ohio State University Nisonger Center, pp. 179–200.

    Google Scholar 

  • Steingard, R., & Biederman, J. (1987). Lithium responsive manic-like symptoms in two individuals with autism and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 932–935.

    Article  PubMed  Google Scholar 

  • Strober, M., Freeman, R., Rigali, J., Schmidt, S., & Diamond, R. (1992). The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 16–20.

    Article  PubMed  Google Scholar 

  • Suppes, T., Baldessarini, R. J., & Faedda, G. L. (1991). Risk of recurrence following discontinuation of lithium in bipolar disorder. Archives of General Psychiatry, 48, 1082–1088.

    PubMed  Google Scholar 

  • Thuppal, M., & Fink, M. (1999). Electroconvulsive therapy and mental retardation. Journal of ECT, 15, 140–149.

    PubMed  Google Scholar 

  • Tillman, R., Geller, B., Bolhofner, K., Craney, J.L. Williams, M., & Zimerman, B. (2003). Ages of onset and rates of syndromal and subsyndromal comorbid DSM—IV diagnoses in a prepupbertal and early adolescent bipolar disorder phenotype. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1486–1493.

    Article  PubMed  Google Scholar 

  • Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., Evans, A.R., Beymer, K., Dube, S., Tollef-son, G. D., & Breier, A. (2003). Efficacy of olanzapine and olanzapine- fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry, 60, 1079–1088.

    Article  PubMed  Google Scholar 

  • Towbin, K. E., Pradella, A., Gorrindo, T., Pine, D., & Leibenluft, E. (2005). Autism spectrum traits in children with mood and anxiety disorders. Journal of Child and Adolescent Psychopharmacology, 15, 452–464.

    Article  PubMed  Google Scholar 

  • Turgay, A., Binder, C., Snyder, R., & Fisman, S. (2002). Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs. Pediatrics, 110, e34.

    Article  PubMed  Google Scholar 

  • Vanstraelen, M., & Tyrer, S. P. (1999). Rapid cycling bipolar affective disorder in people with intellectual disability: A systematic review. Journal of Intellect Disability Research, 43(Pt 5), 349–359.

    Article  Google Scholar 

  • Whittier, M. C., West, S. A., Galli, V. B., & Raute, N. J. (1995). Valproic acid for dysphoric mania in a mentally retarded adolescent. Journal of Clinical Psychiatry, 56, 590–591.

    PubMed  Google Scholar 

  • Wozniak, J., Biederman, J., Faraone, S. V., Frazier, J., Kim, J., Millstein, R., Gershon, J., Thornell, A., Cha, K., & Snyder, J. B. (1997). Mania in children with pervasive developmental disorder revisited. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1552–1559.

    Article  PubMed  Google Scholar 

  • Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978). A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133, 429–435.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zinoviy A. Gutkovich or Gabrielle A. Carlson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Gutkovich, Z.A., Carlson, G.A. (2009). Medication Treatment of Bipolar Disorder in Developmentally Disabled Children and Adolescents. In: Matson, J.L., Andrasik, F., Matson, M.L. (eds) Treating Childhood Psychopathology and Developmental Disabilities. Springer, New York, NY. https://doi.org/10.1007/978-0-387-09530-1_9

Download citation

Publish with us

Policies and ethics